AGL 40.02 Increased By ▲ 0.02 (0.05%)
AIRLINK 127.31 Increased By ▲ 0.27 (0.21%)
BOP 6.60 Decreased By ▼ -0.07 (-1.05%)
CNERGY 4.49 Decreased By ▼ -0.02 (-0.44%)
DCL 8.59 Increased By ▲ 0.04 (0.47%)
DFML 41.79 Increased By ▲ 0.35 (0.84%)
DGKC 87.70 Increased By ▲ 0.85 (0.98%)
FCCL 32.64 Increased By ▲ 0.36 (1.12%)
FFBL 65.02 Increased By ▲ 0.22 (0.34%)
FFL 10.26 Increased By ▲ 0.01 (0.1%)
HUBC 109.69 Increased By ▲ 0.12 (0.11%)
HUMNL 14.70 Increased By ▲ 0.02 (0.14%)
KEL 5.12 Increased By ▲ 0.07 (1.39%)
KOSM 7.57 Increased By ▲ 0.11 (1.47%)
MLCF 41.41 Increased By ▲ 0.03 (0.07%)
NBP 59.70 Decreased By ▼ -0.71 (-1.18%)
OGDC 193.80 Increased By ▲ 3.70 (1.95%)
PAEL 28.40 Increased By ▲ 0.57 (2.05%)
PIBTL 7.79 Decreased By ▼ -0.04 (-0.51%)
PPL 151.75 Increased By ▲ 1.69 (1.13%)
PRL 26.44 Decreased By ▼ -0.44 (-1.64%)
PTC 16.17 Increased By ▲ 0.10 (0.62%)
SEARL 84.00 Decreased By ▼ -2.00 (-2.33%)
TELE 7.64 Decreased By ▼ -0.07 (-0.91%)
TOMCL 35.52 Increased By ▲ 0.11 (0.31%)
TPLP 8.10 Decreased By ▼ -0.02 (-0.25%)
TREET 16.08 Decreased By ▼ -0.33 (-2.01%)
TRG 52.63 Decreased By ▼ -0.66 (-1.24%)
UNITY 26.38 Increased By ▲ 0.22 (0.84%)
WTL 1.25 Decreased By ▼ -0.01 (-0.79%)
BR100 9,953 Increased By 69.4 (0.7%)
BR30 30,908 Increased By 307.7 (1.01%)
KSE100 93,785 Increased By 429.6 (0.46%)
KSE30 29,050 Increased By 119.3 (0.41%)

SEOUL: South Korea has agreed to buy 70,000 courses of Pfizer Inc's experimental antiviral Covid-19 pill, the Korea Disease Control and Prevention Agency (KDCA) said on Saturday.

Pfizer on Friday said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in patients at high risk of severe illness within three days of the onset of coronavirus symptoms.

South Korea has already signed agreements to secure 200,000 courses of Merck & Co Inc's Covid-19 treatment. It is looking to buy an additional 134,000 courses, though it is undecided of which treatment, KDCA said.

Pfizer says antiviral pill cuts risk of severe Covid-19 by 89pc

Last month, the government said it was in talks with Swiss pharmaceutical Roche Holding AG, which is developing an easy-to-administer antiviral pill for Covid-19.

The government had allocated a budget of 36.2 billion won ($30.63 million) for oral Covid-19 antiviral pills.

Pfizer is in talks with 90 countries over supply contracts for Paxlovid, Chief Executive Officer Albert Bourla said in an interview on Friday.

Countries rush to buy Merck, Pfizer's experimental Covid-19 pills

The UK has already secured 480,000 courses of Merck's drug and procured 250,000 courses of the Pfizer treatment.

Comments

Comments are closed.